Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Pravin Dugel

See Remarks at Ocular Therapeutix, Inc (OCUL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 26SEC OCULOcular Therapeutix, Inc Sell Plan 21,6492,525,429 held (−1%) $10.77 $233K -30.0%
May 28SEC OCULOcular Therapeutix, Inc Sell Plan 21,1562,597,170 held (−1%) $8.20 $173K -8.0%
Feb 25SEC OCULOcular Therapeutix, Inc Sell Plan 20,0563,013,022 held (−1%) $8.28 $166K -8.9%
Feb 17SEC OCULOcular Therapeutix, Inc Sell Plan 124,8823,033,078 held (−4%) $9.04 $1.1M -16.6%
Nov 26SEC OCULOcular Therapeutix, Inc Sell Plan 19,5303,157,960 held (−1%) $12.04 $235K -37.4%
  • Sell

    See Remarks Pravin Dugel sold $233K of OCUL at $10.77 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Pravin Dugel sold $173K of OCUL at $8.20 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Pravin Dugel sold $166K of OCUL at $8.28 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Pravin Dugel sold $1.1M of OCUL at $9.04 — pre-scheduled 10b5-1 plan sale.

  • Sell

    See Remarks Pravin Dugel sold $235K of OCUL at $12.04 — pre-scheduled 10b5-1 plan sale.